Call on ‘generics drugs only’ clause after internal talks, says govt

New Delhi : Union health minister Mansukh Mandaviya held a meeting on Monday to discuss contentious issues related to the newly notified regulations by the National Medical Council (NMC). The minister said he will take an ‘appropriate decision’ after internal discussions, people in the know told ET.

The Indian Medical Association (IMA) has vehemently opposed the National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023, which mandate doctors to prescribe only generic drugs. The other contentious issue discussed during the meeting was medical conferences in five-star hotels with cocktail dinners. The NMC has barred doctors from participating in seminars, workshops, or conferences that “involve direct or indirect sponsorships from pharma companies or the allied health sector”.

“The meeting went very well. It lasted two hours as the minister gave the opportunity to everyone. We have presented what the medical fraternity feels. The government will take a decision later on the issues,” said Dr Sharad Agarwal, national president, IMA. The meeting was attended by IMA officials, drug lobby group Indian Pharmaceutical Alliance (IPA), officials from the ministry, and the NMC.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices